Jubilant Pharmova Ltd. - Research Center
530019 JUBLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 403.70 | 427.54 | 47.46 | 40.29 | 1,514.70 |
| Operating profit | 5.00 | 2.93 | -6.94 | 0.16 | 250.49 |
| Interest | 13.50 | 7.29 | 15.91 | 14.68 | 66.93 |
| Gross profit | 25.80 | 112.00 | -7.17 | 95.67 | 205.43 |
| EPS (Rs) | 0.09 | 5.44 | -0.53 | 5.46 | 7.20 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 34.30 | 116.36 | 15.68 | 110.19 | 21.87 |
| Stock adjustment | 20.90 | 32.72 | - | - | 13.49 |
| Raw material | 166.80 | 189.26 | - | - | 749.18 |
| Power and fuel | - | - | - | - | 164.68 |
| Employee expenses | 93.60 | 84.29 | 26.14 | 23.07 | 121.04 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 117.40 | 118.34 | 28.26 | 17.06 | 215.82 |
| Provisions made | - | - | - | - | - |
| Depreciation | 23.30 | 20.29 | 3.19 | 3.06 | 59.12 |
| Taxation | 1.00 | 5.08 | -1.91 | 5.66 | 31.64 |
| Net profit / loss | 1.50 | 86.63 | -8.45 | 86.95 | 114.67 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.90 | 15.93 | 15.93 | 15.93 | 15.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 1.24 | 0.69 | -14.62 | 0.40 | 16.54 |
| GPM (%) | 5.89 | 20.59 | -11.36 | 63.58 | 13.37 |
| NPM (%) | 0.34 | 15.93 | -13.38 | 57.78 | 7.46 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis